Commonwealth Equity Services LLC Buys 631 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Commonwealth Equity Services LLC grew its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 3.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,966 shares of the company’s stock after acquiring an additional 631 shares during the quarter. Commonwealth Equity Services LLC owned about 0.29% of VanEck Pharmaceutical ETF worth $1,550,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bank of Montreal Can increased its position in VanEck Pharmaceutical ETF by 43.6% during the third quarter. Bank of Montreal Can now owns 21,640 shares of the company’s stock valued at $2,052,000 after acquiring an additional 6,570 shares during the last quarter. FMR LLC grew its stake in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares during the period. Townsquare Capital LLC increased its position in shares of VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after purchasing an additional 130 shares during the last quarter. Beck Capital Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 5.2% in the 3rd quarter. Beck Capital Management LLC now owns 22,383 shares of the company’s stock worth $2,127,000 after purchasing an additional 1,109 shares during the period. Finally, Miller Investment Management LP boosted its holdings in shares of VanEck Pharmaceutical ETF by 13.4% in the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after buying an additional 24,446 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Up 0.3 %

PPH opened at $90.65 on Friday. VanEck Pharmaceutical ETF has a 1-year low of $84.48 and a 1-year high of $99.51. The firm’s 50 day simple moving average is $90.74 and its two-hundred day simple moving average is $90.75. The company has a market capitalization of $565.66 million, a PE ratio of 27.82 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.